1. Home
  2. SANG vs MSLE Comparison

SANG vs MSLE Comparison

Compare SANG & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sangoma Technologies Corporation

SANG

Sangoma Technologies Corporation

HOLD

Current Price

$4.31

Market Cap

163.0M

Sector

Technology

ML Signal

HOLD

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$8.46

Market Cap

146.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SANG
MSLE
Founded
1984
N/A
Country
Canada
Canada
Employees
N/A
17
Industry
Computer Software: Programming Data Processing
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
163.0M
146.9M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
SANG
MSLE
Price
$4.31
$8.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.4K
49.9K
Earning Date
05-06-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.71
$5.50
52 Week High
$6.46
$13.39

Technical Indicators

Market Signals
Indicator
SANG
MSLE
Relative Strength Index (RSI) 53.70 57.74
Support Level $3.71 $6.73
Resistance Level $4.71 $9.50
Average True Range (ATR) 0.17 0.75
MACD 0.03 0.19
Stochastic Oscillator 78.39 60.63

Price Performance

Historical Comparison
SANG
MSLE

About SANG Sangoma Technologies Corporation

Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: